In situ gelation of thiolated poly(aspartic acid) derivatives through oxidant-free disulfide formation for ophthalmic drug delivery

Efficient topical treatment of ocular diseases requires a prolonged residence time of drug formulations. An in situ gelling, mucoadhesive system can provide improved residence time while keeps the installation of the formulation easy and accurate due to its low initial viscosity. We synthesized a tw...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Colloids and surfaces, B, Biointerfaces B, Biointerfaces, 2023-05, Vol.225, p.113254-113254, Article 113254
Hauptverfasser: Szilágyi, Barnabás Áron, Gyarmati, Benjámin, Kiss, Eszter L., Budai-Szűcs, Mária, Misra, Anil, Csányi, Erzsébet, László, Krisztina, Szilágyi, András
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 113254
container_issue
container_start_page 113254
container_title Colloids and surfaces, B, Biointerfaces
container_volume 225
creator Szilágyi, Barnabás Áron
Gyarmati, Benjámin
Kiss, Eszter L.
Budai-Szűcs, Mária
Misra, Anil
Csányi, Erzsébet
László, Krisztina
Szilágyi, András
description Efficient topical treatment of ocular diseases requires a prolonged residence time of drug formulations. An in situ gelling, mucoadhesive system can provide improved residence time while keeps the installation of the formulation easy and accurate due to its low initial viscosity. We synthesized a two-component, biocompatible water-based liquid formulation showing in situ gelation upon mixing. S-protected, preactivated derivatives of thiolated poly(aspartic acid) (PASP-SS-MNA) were synthesized by coupling the free thiol groups of thiolated poly(aspartic acid) (PASP-SH) with 6-mercaptonicotinic acid (MNA). The amount of protecting groups was 242, 341, and 530 µmol/g depending on the degree of thiolation of PASP. The chemical interaction between PASP-SS-MNA and mucin was proven, indicating the mucoadhesive properties. Disulfide cross-linked hydrogels were formed in situ without an oxidizing agent by mixing the aqueous solutions of PASP-SS-MNA and PASP-SH. The gelation time was controlled between 1 and 6 min, while the storage modulus was as high as 4–16 kPa depending on the composition. Swelling experiments showed that hydrogels with no residual thiol groups are stable in phosphate-buffered saline at pH = 7.4. In contrast, the presence of free thiol groups leads to the dissolution of the hydrogel with a rate depending on the excess of thiol groups. The biological safety of the polymers and MNA was confirmed on Madin-Darby Canine Kidney cell line. Furthermore, a prolonged release of ofloxacin was observed at pH = 7.4 compared to a conventional liquid formulation, supporting the potential of the developed biopolymers in ophthalmic drug delivery. [Display omitted] •S-protected, preactivated derivatives of thiolated poly(aspartic acid) were synthesized.•The polymers form covalent bonds with mucin protein by thiol-disulfide exchange reaction.•The solutions of S-protected poly(aspartic acid) and thiolated poly(aspartic acid) form hydrogels.•Prolonged release of ofloxacin was observed from the poly(aspartic acid) hydrogels.
doi_str_mv 10.1016/j.colsurfb.2023.113254
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2834210565</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0927776523001327</els_id><sourcerecordid>2834210565</sourcerecordid><originalsourceid>FETCH-LOGICAL-c401t-25fcf00acc9f73b2dcbcee2408a6779ea578f1e257a265b51711a9250055cc0e3</originalsourceid><addsrcrecordid>eNqFkctu3CAUQFHUKpk8fiFimS485WHA3rWK0jZSpG7aNcJwmWFkGxfsUWedHy-Rk26zAqRzz5U4CN1SsqWEys-HrY19XpLvtowwvqWUM1GfoQ1tFK9qLtUHtCEtU5VSUlygy5wPhBBWU3WOLrhsWyk526DnxxHnMC94B72ZQxxx9Hjeh1he4PAU-9OdyZNJc7DY2OA-YQcpHAt7hFzIFJfdHse_wZlxrnwCwC7kpffBAfYxDau13HCc9vPe9EMxubTsiqgvknS6Rh-96TPcvJ5X6Pe3h1_3P6qnn98f778-VbYmdK6Y8NYTYqxtveIdc7azAKwmjZFKtWCEajwFJpRhUnSCKkpNywQhQlhLgF-hu9U7pfhngTzrIWQLfW9GiEvWrOE1o0RI8T6qWt42sqayoHJFbYo5J_B6SmEw6aQp0S-t9EG_tdIvrfTaqgzevu5YugHc_7G3OAX4sgJQPuUYIOlsA4wWXEhgZ-1ieG_HPziBq3s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2793986416</pqid></control><display><type>article</type><title>In situ gelation of thiolated poly(aspartic acid) derivatives through oxidant-free disulfide formation for ophthalmic drug delivery</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Szilágyi, Barnabás Áron ; Gyarmati, Benjámin ; Kiss, Eszter L. ; Budai-Szűcs, Mária ; Misra, Anil ; Csányi, Erzsébet ; László, Krisztina ; Szilágyi, András</creator><creatorcontrib>Szilágyi, Barnabás Áron ; Gyarmati, Benjámin ; Kiss, Eszter L. ; Budai-Szűcs, Mária ; Misra, Anil ; Csányi, Erzsébet ; László, Krisztina ; Szilágyi, András</creatorcontrib><description>Efficient topical treatment of ocular diseases requires a prolonged residence time of drug formulations. An in situ gelling, mucoadhesive system can provide improved residence time while keeps the installation of the formulation easy and accurate due to its low initial viscosity. We synthesized a two-component, biocompatible water-based liquid formulation showing in situ gelation upon mixing. S-protected, preactivated derivatives of thiolated poly(aspartic acid) (PASP-SS-MNA) were synthesized by coupling the free thiol groups of thiolated poly(aspartic acid) (PASP-SH) with 6-mercaptonicotinic acid (MNA). The amount of protecting groups was 242, 341, and 530 µmol/g depending on the degree of thiolation of PASP. The chemical interaction between PASP-SS-MNA and mucin was proven, indicating the mucoadhesive properties. Disulfide cross-linked hydrogels were formed in situ without an oxidizing agent by mixing the aqueous solutions of PASP-SS-MNA and PASP-SH. The gelation time was controlled between 1 and 6 min, while the storage modulus was as high as 4–16 kPa depending on the composition. Swelling experiments showed that hydrogels with no residual thiol groups are stable in phosphate-buffered saline at pH = 7.4. In contrast, the presence of free thiol groups leads to the dissolution of the hydrogel with a rate depending on the excess of thiol groups. The biological safety of the polymers and MNA was confirmed on Madin-Darby Canine Kidney cell line. Furthermore, a prolonged release of ofloxacin was observed at pH = 7.4 compared to a conventional liquid formulation, supporting the potential of the developed biopolymers in ophthalmic drug delivery. [Display omitted] •S-protected, preactivated derivatives of thiolated poly(aspartic acid) were synthesized.•The polymers form covalent bonds with mucin protein by thiol-disulfide exchange reaction.•The solutions of S-protected poly(aspartic acid) and thiolated poly(aspartic acid) form hydrogels.•Prolonged release of ofloxacin was observed from the poly(aspartic acid) hydrogels.</description><identifier>ISSN: 0927-7765</identifier><identifier>EISSN: 1873-4367</identifier><identifier>DOI: 10.1016/j.colsurfb.2023.113254</identifier><identifier>PMID: 36996632</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Aspartic Acid ; bioadhesives ; cell lines ; crosslinking ; Disulfides ; Dogs ; Drug Delivery Systems ; gelation ; Hydrogels ; kidneys ; liquids ; mucins ; Mucoadhesion ; ofloxacin ; Oxidant-free in situ gelation ; Oxidants ; Preactivated ; storage modulus ; Sulfhydryl Compounds - chemistry ; Thiol-disulfide exchange ; Thiolated poly(aspartic acid) ; thiols ; viscosity</subject><ispartof>Colloids and surfaces, B, Biointerfaces, 2023-05, Vol.225, p.113254-113254, Article 113254</ispartof><rights>2023 Elsevier B.V.</rights><rights>Copyright © 2023 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c401t-25fcf00acc9f73b2dcbcee2408a6779ea578f1e257a265b51711a9250055cc0e3</citedby><cites>FETCH-LOGICAL-c401t-25fcf00acc9f73b2dcbcee2408a6779ea578f1e257a265b51711a9250055cc0e3</cites><orcidid>0000-0003-4499-3983 ; 0000-0001-6898-1755 ; 0000-0002-8795-7264</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.colsurfb.2023.113254$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36996632$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Szilágyi, Barnabás Áron</creatorcontrib><creatorcontrib>Gyarmati, Benjámin</creatorcontrib><creatorcontrib>Kiss, Eszter L.</creatorcontrib><creatorcontrib>Budai-Szűcs, Mária</creatorcontrib><creatorcontrib>Misra, Anil</creatorcontrib><creatorcontrib>Csányi, Erzsébet</creatorcontrib><creatorcontrib>László, Krisztina</creatorcontrib><creatorcontrib>Szilágyi, András</creatorcontrib><title>In situ gelation of thiolated poly(aspartic acid) derivatives through oxidant-free disulfide formation for ophthalmic drug delivery</title><title>Colloids and surfaces, B, Biointerfaces</title><addtitle>Colloids Surf B Biointerfaces</addtitle><description>Efficient topical treatment of ocular diseases requires a prolonged residence time of drug formulations. An in situ gelling, mucoadhesive system can provide improved residence time while keeps the installation of the formulation easy and accurate due to its low initial viscosity. We synthesized a two-component, biocompatible water-based liquid formulation showing in situ gelation upon mixing. S-protected, preactivated derivatives of thiolated poly(aspartic acid) (PASP-SS-MNA) were synthesized by coupling the free thiol groups of thiolated poly(aspartic acid) (PASP-SH) with 6-mercaptonicotinic acid (MNA). The amount of protecting groups was 242, 341, and 530 µmol/g depending on the degree of thiolation of PASP. The chemical interaction between PASP-SS-MNA and mucin was proven, indicating the mucoadhesive properties. Disulfide cross-linked hydrogels were formed in situ without an oxidizing agent by mixing the aqueous solutions of PASP-SS-MNA and PASP-SH. The gelation time was controlled between 1 and 6 min, while the storage modulus was as high as 4–16 kPa depending on the composition. Swelling experiments showed that hydrogels with no residual thiol groups are stable in phosphate-buffered saline at pH = 7.4. In contrast, the presence of free thiol groups leads to the dissolution of the hydrogel with a rate depending on the excess of thiol groups. The biological safety of the polymers and MNA was confirmed on Madin-Darby Canine Kidney cell line. Furthermore, a prolonged release of ofloxacin was observed at pH = 7.4 compared to a conventional liquid formulation, supporting the potential of the developed biopolymers in ophthalmic drug delivery. [Display omitted] •S-protected, preactivated derivatives of thiolated poly(aspartic acid) were synthesized.•The polymers form covalent bonds with mucin protein by thiol-disulfide exchange reaction.•The solutions of S-protected poly(aspartic acid) and thiolated poly(aspartic acid) form hydrogels.•Prolonged release of ofloxacin was observed from the poly(aspartic acid) hydrogels.</description><subject>Animals</subject><subject>Aspartic Acid</subject><subject>bioadhesives</subject><subject>cell lines</subject><subject>crosslinking</subject><subject>Disulfides</subject><subject>Dogs</subject><subject>Drug Delivery Systems</subject><subject>gelation</subject><subject>Hydrogels</subject><subject>kidneys</subject><subject>liquids</subject><subject>mucins</subject><subject>Mucoadhesion</subject><subject>ofloxacin</subject><subject>Oxidant-free in situ gelation</subject><subject>Oxidants</subject><subject>Preactivated</subject><subject>storage modulus</subject><subject>Sulfhydryl Compounds - chemistry</subject><subject>Thiol-disulfide exchange</subject><subject>Thiolated poly(aspartic acid)</subject><subject>thiols</subject><subject>viscosity</subject><issn>0927-7765</issn><issn>1873-4367</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkctu3CAUQFHUKpk8fiFimS485WHA3rWK0jZSpG7aNcJwmWFkGxfsUWedHy-Rk26zAqRzz5U4CN1SsqWEys-HrY19XpLvtowwvqWUM1GfoQ1tFK9qLtUHtCEtU5VSUlygy5wPhBBWU3WOLrhsWyk526DnxxHnMC94B72ZQxxx9Hjeh1he4PAU-9OdyZNJc7DY2OA-YQcpHAt7hFzIFJfdHse_wZlxrnwCwC7kpffBAfYxDau13HCc9vPe9EMxubTsiqgvknS6Rh-96TPcvJ5X6Pe3h1_3P6qnn98f778-VbYmdK6Y8NYTYqxtveIdc7azAKwmjZFKtWCEajwFJpRhUnSCKkpNywQhQlhLgF-hu9U7pfhngTzrIWQLfW9GiEvWrOE1o0RI8T6qWt42sqayoHJFbYo5J_B6SmEw6aQp0S-t9EG_tdIvrfTaqgzevu5YugHc_7G3OAX4sgJQPuUYIOlsA4wWXEhgZ-1ieG_HPziBq3s</recordid><startdate>20230501</startdate><enddate>20230501</enddate><creator>Szilágyi, Barnabás Áron</creator><creator>Gyarmati, Benjámin</creator><creator>Kiss, Eszter L.</creator><creator>Budai-Szűcs, Mária</creator><creator>Misra, Anil</creator><creator>Csányi, Erzsébet</creator><creator>László, Krisztina</creator><creator>Szilágyi, András</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><orcidid>https://orcid.org/0000-0003-4499-3983</orcidid><orcidid>https://orcid.org/0000-0001-6898-1755</orcidid><orcidid>https://orcid.org/0000-0002-8795-7264</orcidid></search><sort><creationdate>20230501</creationdate><title>In situ gelation of thiolated poly(aspartic acid) derivatives through oxidant-free disulfide formation for ophthalmic drug delivery</title><author>Szilágyi, Barnabás Áron ; Gyarmati, Benjámin ; Kiss, Eszter L. ; Budai-Szűcs, Mária ; Misra, Anil ; Csányi, Erzsébet ; László, Krisztina ; Szilágyi, András</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c401t-25fcf00acc9f73b2dcbcee2408a6779ea578f1e257a265b51711a9250055cc0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Animals</topic><topic>Aspartic Acid</topic><topic>bioadhesives</topic><topic>cell lines</topic><topic>crosslinking</topic><topic>Disulfides</topic><topic>Dogs</topic><topic>Drug Delivery Systems</topic><topic>gelation</topic><topic>Hydrogels</topic><topic>kidneys</topic><topic>liquids</topic><topic>mucins</topic><topic>Mucoadhesion</topic><topic>ofloxacin</topic><topic>Oxidant-free in situ gelation</topic><topic>Oxidants</topic><topic>Preactivated</topic><topic>storage modulus</topic><topic>Sulfhydryl Compounds - chemistry</topic><topic>Thiol-disulfide exchange</topic><topic>Thiolated poly(aspartic acid)</topic><topic>thiols</topic><topic>viscosity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Szilágyi, Barnabás Áron</creatorcontrib><creatorcontrib>Gyarmati, Benjámin</creatorcontrib><creatorcontrib>Kiss, Eszter L.</creatorcontrib><creatorcontrib>Budai-Szűcs, Mária</creatorcontrib><creatorcontrib>Misra, Anil</creatorcontrib><creatorcontrib>Csányi, Erzsébet</creatorcontrib><creatorcontrib>László, Krisztina</creatorcontrib><creatorcontrib>Szilágyi, András</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><jtitle>Colloids and surfaces, B, Biointerfaces</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Szilágyi, Barnabás Áron</au><au>Gyarmati, Benjámin</au><au>Kiss, Eszter L.</au><au>Budai-Szűcs, Mária</au><au>Misra, Anil</au><au>Csányi, Erzsébet</au><au>László, Krisztina</au><au>Szilágyi, András</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In situ gelation of thiolated poly(aspartic acid) derivatives through oxidant-free disulfide formation for ophthalmic drug delivery</atitle><jtitle>Colloids and surfaces, B, Biointerfaces</jtitle><addtitle>Colloids Surf B Biointerfaces</addtitle><date>2023-05-01</date><risdate>2023</risdate><volume>225</volume><spage>113254</spage><epage>113254</epage><pages>113254-113254</pages><artnum>113254</artnum><issn>0927-7765</issn><eissn>1873-4367</eissn><abstract>Efficient topical treatment of ocular diseases requires a prolonged residence time of drug formulations. An in situ gelling, mucoadhesive system can provide improved residence time while keeps the installation of the formulation easy and accurate due to its low initial viscosity. We synthesized a two-component, biocompatible water-based liquid formulation showing in situ gelation upon mixing. S-protected, preactivated derivatives of thiolated poly(aspartic acid) (PASP-SS-MNA) were synthesized by coupling the free thiol groups of thiolated poly(aspartic acid) (PASP-SH) with 6-mercaptonicotinic acid (MNA). The amount of protecting groups was 242, 341, and 530 µmol/g depending on the degree of thiolation of PASP. The chemical interaction between PASP-SS-MNA and mucin was proven, indicating the mucoadhesive properties. Disulfide cross-linked hydrogels were formed in situ without an oxidizing agent by mixing the aqueous solutions of PASP-SS-MNA and PASP-SH. The gelation time was controlled between 1 and 6 min, while the storage modulus was as high as 4–16 kPa depending on the composition. Swelling experiments showed that hydrogels with no residual thiol groups are stable in phosphate-buffered saline at pH = 7.4. In contrast, the presence of free thiol groups leads to the dissolution of the hydrogel with a rate depending on the excess of thiol groups. The biological safety of the polymers and MNA was confirmed on Madin-Darby Canine Kidney cell line. Furthermore, a prolonged release of ofloxacin was observed at pH = 7.4 compared to a conventional liquid formulation, supporting the potential of the developed biopolymers in ophthalmic drug delivery. [Display omitted] •S-protected, preactivated derivatives of thiolated poly(aspartic acid) were synthesized.•The polymers form covalent bonds with mucin protein by thiol-disulfide exchange reaction.•The solutions of S-protected poly(aspartic acid) and thiolated poly(aspartic acid) form hydrogels.•Prolonged release of ofloxacin was observed from the poly(aspartic acid) hydrogels.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>36996632</pmid><doi>10.1016/j.colsurfb.2023.113254</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-4499-3983</orcidid><orcidid>https://orcid.org/0000-0001-6898-1755</orcidid><orcidid>https://orcid.org/0000-0002-8795-7264</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0927-7765
ispartof Colloids and surfaces, B, Biointerfaces, 2023-05, Vol.225, p.113254-113254, Article 113254
issn 0927-7765
1873-4367
language eng
recordid cdi_proquest_miscellaneous_2834210565
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Aspartic Acid
bioadhesives
cell lines
crosslinking
Disulfides
Dogs
Drug Delivery Systems
gelation
Hydrogels
kidneys
liquids
mucins
Mucoadhesion
ofloxacin
Oxidant-free in situ gelation
Oxidants
Preactivated
storage modulus
Sulfhydryl Compounds - chemistry
Thiol-disulfide exchange
Thiolated poly(aspartic acid)
thiols
viscosity
title In situ gelation of thiolated poly(aspartic acid) derivatives through oxidant-free disulfide formation for ophthalmic drug delivery
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T18%3A44%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20situ%20gelation%20of%20thiolated%20poly(aspartic%20acid)%20derivatives%20through%20oxidant-free%20disulfide%20formation%20for%20ophthalmic%20drug%20delivery&rft.jtitle=Colloids%20and%20surfaces,%20B,%20Biointerfaces&rft.au=Szil%C3%A1gyi,%20Barnab%C3%A1s%20%C3%81ron&rft.date=2023-05-01&rft.volume=225&rft.spage=113254&rft.epage=113254&rft.pages=113254-113254&rft.artnum=113254&rft.issn=0927-7765&rft.eissn=1873-4367&rft_id=info:doi/10.1016/j.colsurfb.2023.113254&rft_dat=%3Cproquest_cross%3E2834210565%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2793986416&rft_id=info:pmid/36996632&rft_els_id=S0927776523001327&rfr_iscdi=true